9-methyl-3,9-diazaspiro[5.6]dodecan-10-one dihydrochloride, 95.0%, 10g

4-((4-Ethyl-2,6-difluorophenyl)ethynyl)-4'-propyl-1,1'-biphenyl, 97%, 1g

(R)-2-Amino-N-(4-methyl-2-oxo-2H-chromen-7-yl)propanamide 2,2,2-trifluoroacetate, 95%, 1g

tert-Butyl 4-hydroxy-2,2-dimethylpyrrolidine-1-carboxylate, 98%, 1g

2-Methylstilbene>98.0%(GC)5g

Ethyl 6,8-dibromoimidazo[1,2-a]pyrazine-2-carboxylate, 95.0%, 1g

6-Chloro-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazolo[4,3-c]pyridine, 95.0%, 500mg

(R)-2-Amino-1,1,1-trifluoropropane hydrochloride, 99.0%, 100g

Acetone Min 99.5% For Synthesis Glass Packaging 2.5L Glass Packaging

1-(4-Fluorophenyl)ethylamine, 97.0%, 1g

tert-Butyl 3,3-dimethyl-4-oxopyrrolidine-1-carboxylate, 95%, 5g

Mubritinib, 99%, 50mg

1-(5-Bromo-2-fluorophenyl)-2,2,2-trifluoroethanol, 95%, 250mg